Lyell Immunopharma Inc (LYEL) — Free Cash Flow Generation Index
Lyell Immunopharma Inc (LYEL) has a Free Cash Flow Generation Index of 0.59x as of December 2019. Free cash flow of $23.43 Million represents 1% of operating cash flow ($39.47 Million). See how liquid is Lyell Immunopharma Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Lyell Immunopharma Inc Free Cash Flow Generation Index (2019–2019)
Historical FCF Generation Index trend for Lyell Immunopharma Inc across 1 annual periods. Explore Lyell Immunopharma Inc (LYEL) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Lyell Immunopharma Inc (2019–2019)
Year-by-year Free Cash Flow Generation Index for Lyell Immunopharma Inc. For the full company profile including market capitalisation, see LYEL company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | 0.59x | $23.43 Million | $39.47 Million | $16.05 Million | — |